SCHEMBL7336982

SCHEMBL7336982

O=C(O)[C@@H]1CCCN1C(=S)NC1CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
KMT2A Q03164 2/20 0.51
ALDH1A1 P00352 1/20 0.50
HPGD P15428 1/20 0.50
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
FKBP1A P62942 2/20 0.46
MAPK1 P28482 2/20 0.46
POLB P06746 3/20 0.45
NPSR1 Q6W5P4 3/20 0.44
MAPT P10636 2/20 0.44
MEN1 O00255 1/20 0.44
MCOLN3 Q8TDD5 1/20 0.44
NPC1 O15118 2/20 0.43
RAB9A P51151 1/20 0.43
DUSP3 P51452 1/20 0.43
PTPN5 P54829 1/20 0.43
PTPN11 Q06124 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7405457 1.00 KDM4E (0.53) KDM4ESMN1; SMN2KMT2AALDH1A1HPGD
SCHEMBL5950255 0.83 KDM4E (0.73) KDM4ESMN1; SMN2KMT2AALDH1A1POLB
SCHEMBL6534174 0.83 KDM4E (0.73) KDM4ESMN1; SMN2KMT2AALDH1A1POLB
SCHEMBL7670891 0.77 KDM4E (0.69) KDM4ESMN1; SMN2KMT2AALDH1A1POLB
SCHEMBL7837671 0.77 KDM4E (0.69) KDM4ESMN1; SMN2KMT2AALDH1A1POLB
SCHEMBL6512359 0.72 ACE (0.50)
SCHEMBL2194754 0.72 ACE (0.50)
SCHEMBL21874335 0.71 ACE (0.49)
SCHEMBL27957044 0.71 ACE (0.49)
SCHEMBL3791081 0.71 ACE (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242468-B1 Carbamate and urea compositions and neurotrophic uses GLIAMED, INC. 2001-06-05 US claimed
US-6395758-B1 VISION DEFECTS GPI NIL HOLDINGS, INC. 2002-05-28 US disclosed
EP-1107757-A2 CARBAMATE AND UREA COMPOSITIONS AND NEUROTROPHIC USES GUILFORD PHARMACEUTICALS INC. (US) 2001-06-20 EP disclosed
US-6242468-B1 Carbamate and urea compositions and neurotrophic uses GLIAMED, INC. 2001-06-05 US disclosed
US-6194440-B1 Small molecule carbamate or urea hair growth compositions and uses GPI NIL HOLDINGS, INC. 2001-02-27 US disclosed
EP-1011650-A1 METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS Amgen Inc., (US) 2000-06-28 EP disclosed
WO-2000010553-A2 CARBAMATE AND UREA COMPOSITIONS AND NEUROTROPHIC USES GPI NIL HOLDINGS, INC. (US) 2000-03-02 WO disclosed
WO-1999014998-A2 METHOD FOR PREVENTING AND TREATING HEARING LOSS USING SENSORINEUROTROPHIC COMPOUNDS AMGEN INC. (US) 1999-04-01 WO disclosed